NOVARTIS PHARMS FDA Approval BLA 125290

BLA 125290

NOVARTIS PHARMS

FDA Drug Application

Application #125290

Documents

Letter2016-05-16
Letter2015-12-23
Label2015-12-28
Letter2009-08-25
Letter2014-12-30
Letter2012-03-20
Label2009-08-20
Label2016-05-17
Review2010-04-22
Summary Review2010-04-22
Label2018-12-12
Letter2018-12-20
Letter2019-08-20
Label2019-08-20
Medication Guide2019-08-20
Letter2020-10-05
Label2020-10-07
Medication Guide2020-10-07
Letter2021-11-05
Label2021-11-05
Medication Guide2021-11-05

Application Sponsors

BLA 125290NOVARTIS PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE; SUBCUTANEOUS0.0625MG2EXTAVIAINTERFERON BETA-1B

FDA Submissions

UNKNOWN; ORIG1AP2009-08-14STANDARD
LABELING; LabelingSUPPL29AP2014-12-22STANDARD
LABELING; LabelingSUPPL30AP2011-06-22STANDARD
LABELING; LabelingSUPPL33AP2012-03-18STANDARD
LABELING; LabelingSUPPL62AP2016-05-12STANDARD
LABELING; LabelingSUPPL63AP2015-12-22STANDARD
LABELING; LabelingSUPPL66AP2018-12-11STANDARD
LABELING; LabelingSUPPL67AP2019-08-16STANDARD
LABELING; LabelingSUPPL70AP2020-10-02STANDARD
LABELING; LabelingSUPPL73AP2021-11-03STANDARD

Submissions Property Types

SUPPL29Null15
SUPPL30Null7
SUPPL62Null15
SUPPL63Null6
SUPPL66Null33
SUPPL67Null7
SUPPL70Null6
SUPPL73Null15

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 125290
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.